ArticleTranslational lung cancer research2019

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial.

Robert A Belderbos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.